Company news

Century Therapeutics, Inc. news in 2023

Century Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

December 8, 2023

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

December 5, 2023

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus

December 5, 2023

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

November 20, 2023

Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

November 8, 2023

Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer

November 8, 2023

Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases

November 8, 2023

Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and Exposition

November 1, 2023

Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference

September 25, 2023

Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

August 8, 2023

Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

May 10, 2023

Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit

April 16, 2023

Century Therapeutics Announces Leadership Changes

April 11, 2023

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

March 15, 2023

Century Therapeutics to Present at the AACR Annual Meeting 2023

March 14, 2023

Century Therapeutics to Present at Upcoming Investor Conferences

February 20, 2023

Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas

February 7, 2023

Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026

January 4, 2023

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 3, 2023

Decks in 2023